SOLIGENIX, INC. Share Price
SOLIGENIX, INC. (SNGX) had Share Price of $1.35 per share as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2026-03-31
- 2025-12-31: Share Price $1.35.
- 2025-09-30: Share Price $1.35.
- 2025-09-29: Share Price $7.50.
- 2024-12-31: Share Price $6.40.
| Period end | Share Price |
|---|---|
| 2025-12-31 | $1.35 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.35 10-Q · filed 2025-11-07 |
| 2025-09-29 | $7.50 10-Q · filed 2025-11-07 |
| 2024-12-31 | $6.40 10-K · filed 2026-03-31 |
| 2024-04-22 | $6.40 10-K · filed 2025-03-21 |
| 2020-03-31 | $2.56 10-Q · filed 2020-08-14 |
| 2019-09-15 | $1.05 10-K · filed 2021-03-30 |
| 2019-08-15 | $0.88 10-K · filed 2021-03-30 |
| 2019-07-15 | $0.98 10-K · filed 2021-03-30 |
| 2019-07-02 | $0.72 10-K · filed 2021-03-30 |
| 2019-06-28 | $0.71 10-K · filed 2021-03-30 |
| 2019-05-15 | $0.83 10-K · filed 2021-03-30 |
| 2019-04-29 | $0.73 10-K · filed 2021-03-30 |
| 2019-01-02 | $0.96 10-K · filed 2021-03-30 |
| 2017-11-03 | $2.00 10-K · filed 2019-03-26 |
| 2014-12-31 | $0.61 10-K · filed 2015-03-25 |
| 2013-12-31 | $1.80 10-K · filed 2015-03-25 |
| 2013-06-25 | $0.96 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |